Abstract
Schistosomiasis is a neglected tropical disease responsible for the death of more than 300,000 people every year. The disease is caused by intravascular parasitic platyhelminths called schistosomes. Treatment and control of schistosomiasis rely on a single drug, praziquantel, and concern exists over the possible emergence of resistance to this drug. The recent completion of the genome sequences of the three main worm species that cause schistosomiasis in humans has raised hope for the development of new interventions to treat the disease. RNA interference (RNAi), a mechanism by which gene-specific double-stranded RNA (dsRNA) triggers degradation of homologous mRNA transcripts, has emerged as an important tool to evaluate and validate new potential drug targets. In addition, RNAi has been used to explore the basic biology of these debilitating parasites. RNAi can be achieved in all stages of the parasite’s life cycle in which it has been tested. In this review, we describe methods for applying RNAi to suppress gene expression in the intra-mammalian life stages (adults and schistosomula) of Schistosoma mansoni. We describe procedures for isolating and culturing the parasites, preparing and delivering dsRNA targeting a specific gene, as well as a procedure to evaluate gene suppression by quantitative real-time PCR.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Steinmann P, Keiser J, Bos R, Tanner M, Utzinger J (2006) Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect Dis 6:411–425
Ross AG, Bartley PB, Sleigh AC, Olds GR, Li Y, Williams GM et al (2002) Schistosomiasis. N Engl J Med 346:1212–1220
Abdul-Ghani R, Loutfy N, el-Sahn A, Hassan A (2009) Current chemotherapy arsenal for schistosomiasis mansoni: alternatives and challenges. Parasitol Res 104:955–965
Doenhoff MJ, Pica-Mattoccia L (2006) Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4:199–210
Melman SD, Steinauer ML, Cunningham C, Kubatko LS, Mwangi IN, Wynn NB et al (2009) Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoni. PLoS Negl Trop Dis 3:e504
Doenhoff MJ, Cioli D, Utzinger J (2008) Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659–667
Berriman M, Haas BJ, LoVerde PT, Wilson RA, Dillon GP, Cerqueira GC et al (2009) The genome of the blood fluke Schistosoma mansoni. Nature 460:352–358
Schistosoma japonicum Genome Sequencing and Functional Analysis and Consortium (2009) The Schistosoma japonicum genome reveals features of host-parasite interplay. Nature 460: 345–351
Young ND, Jex AR, Li B, Liu S, Yang L, Xiong Z et al (2012) Whole-genome sequence of Schistosoma haematobium. Nat Genet 44: 221–225
Skelly PJ, Da’dara A, Harn D (2003) Suppression of cathepsin B expression in Schistosoma mansoni by RNA interference. Int J Parasitol 33: 363–369
Boyle JP, Wu XJ, Shoemaker CB, Yoshino TP (2003) Using RNA interference to manipulate endogenous gene expression in Schistosoma mansoni sporocysts. Mol Biochem Parasitol 128:205–215
Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE, Mello CC (1998) Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans [see comments]. Nature 391:806–811
Tabara H, Grishok A, Mello CC (1998) RNAi in C. elegans: soaking in the genome sequence. Science 282:430–431
Hunter CP (1999) Genetics: a touch of elegance with RNAi. Curr Biol 9:R440–R442
Kennerdell JR, Carthew RW (1998) Use of dsRNA-mediated genetic interference to demonstrate that frizzled and frizzled 2 act in the wingless pathway. Cell 95:1017–1026
Wianny F, Zernicka-Goetz M (2000) Specific interference with gene function by double-stranded RNA in early mouse development. Nat Cell Biol 2:70–75
Schoppmeier M, Damen WG (2001) Double-stranded RNA interference in the spider Cupiennius salei: the role of Distal-less is evolutionarily conserved in arthropod appendage formation. Dev Genes Evol 211:76–82
Morris JC, Wang Z, Drew ME, Englund PT (2002) Glycolysis modulates trypanosome glycoprotein expression as revealed by an RNAi library. EMBO J 21:4429–4438
Shi H, Djikeng A, Tschudi C, Ullu E (2004) Argonaute protein in the early divergent eukaryote Trypanosoma brucei: control of small interfering RNA accumulation and retroposon transcript abundance. Mol Cell Biol 24: 420–427
Petrocca F, Lieberman J (2011) Promise and challenge of RNA interference-based therapy for cancer. J Clin Oncol 29:747–754
Nemunaitis J, Rao DD, Liu SH, Brunicardi FC (2011) Personalized cancer approach: using RNA interference technology. World J Surg 35(8):1700–1714
Davidson BL, McCray PB Jr (2011) Current prospects for RNA interference-based therapies. Nat Rev Genet 12:329–340
Hong-Geller E, Micheva-Viteva SN (2010) Functional gene discovery using RNA interference-based genomic screens to combat pathogen infection. Curr Drug Discov Technol 7:86–94
Kuntz AN, Davioud-Charvet E, Sayed AA, Califf LL, Dessolin J, Arner ES et al (2007) Thioredoxin glutathione reductase from Schistosoma mansoni: an essential parasite enzyme and a key drug target. PLoS Med 4:e206
Bhardwaj R, Krautz-Peterson G, Da’dara A, Tzipori S, Skelly PJ (2011) Tegumental phosphodiesterase SmNPP-5 is a virulence factor for schistosomes. Infect Immun 79:4276–4284
Ndegwa D, Krautz-Peterson G, Skelly PJ (2007) Protocols for gene silencing in schistosomes. Exp Parasitol 117:284–291
Krautz-Peterson G, Radwanska M, Ndegwa D, Shoemaker CB, Skelly PJ (2007) Optimizing gene suppression in schistosomes using RNA interference. Mol Biochem Parasitol 153: 194–202
Stefanic S, Dvorak J, Horn M, Braschi S, Sojka D, Ruelas DS et al (2010) RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening. PLoS Negl Trop Dis 4:e850
Mourao MM, Dinguirard N, Franco GR, Yoshino TP (2009) Phenotypic screen of early-developing larvae of the blood fluke, schistosoma mansoni, using RNA interference. PLoS Negl Trop Dis 3:e502
Krautz-Peterson G, Simoes M, Faghiri Z, Ndegwa D, Oliveira G, Shoemaker CB et al (2010) Suppressing glucose transporter gene expression in schistosomes impairs parasite feeding and decreases survival in the mammalian host. PLoS Pathog 6:e1000932
Faghiri Z, Skelly PJ (2009) The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake. FASEB J 23:2780–2789
Correnti JM, Brindley PJ, Pearce EJ (2005) Long-term suppression of cathepsin B levels by RNA interference retards schistosome growth. Mol Biochem Parasitol 143: 209–215
Krautz-Peterson G, Bhardwaj R, Faghiri Z, Tararam CA, Skelly PJ (2010) RNA interference in schistosomes: machinery and methodology. Parasitology 137:485–495
Rinaldi G, Morales ME, Alrefaei YN, Cancela M, Castillo E, Dalton JP et al (2009) RNA interference targeting leucine aminopeptidase blocks hatching of Schistosoma mansoni eggs. Mol Biochem Parasitol 167:118–126
Lewis F (2001) Schistosomiasis. Curr Protoc Immunol Chapter 19: Unit 19 11
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25:402–408
Acknowledgments
This work was supported by the National Institutes of Health-National Institute of Allergy and Infectious Diseases (grant number AI-056273). Schistosome-infected snails were provided by the Biomedical Research Institute through the National Institutes of Health (NIAID contract number HHSN272201000009I).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Da’dara, A.A., Skelly, P.J. (2015). Gene Suppression in Schistosomes Using RNAi. In: Peacock, C. (eds) Parasite Genomics Protocols. Methods in Molecular Biology, vol 1201. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1438-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1438-8_8
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1437-1
Online ISBN: 978-1-4939-1438-8
eBook Packages: Springer Protocols